GLP1R and type 2 diabetes mellitus: The study on Glucagon-like peptide-1 (GLP-1) treatment in rats with type II diabetes demonstrates that GLP-1 reduces oxidative stress-induced autophagy by activating the GLP-1R-ERK1/2-HDAC6 signaling pathway.